Research ArticleHuman Studies
Serum Thyroglobulin and Iodine-131 Whole-Body Scan in the Diagnosis and Assessment of Treatment for Metastatic Differentiated Thyroid Carcinoma
Ernesto Lubin, Sara Mechlis-Frish, Sofia Zatz, Aharon Shimoni, Karl Segal, Aristede Avraham, Rudi Levy and Raphael Feinmesser
Journal of Nuclear Medicine February 1994, 35 (2) 257-262;
Ernesto Lubin
Sara Mechlis-Frish
Sofia Zatz
Aharon Shimoni
Karl Segal
Aristede Avraham
Rudi Levy


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Serum Thyroglobulin and Iodine-131 Whole-Body Scan in the Diagnosis and Assessment of Treatment for Metastatic Differentiated Thyroid Carcinoma
Ernesto Lubin, Sara Mechlis-Frish, Sofia Zatz, Aharon Shimoni, Karl Segal, Aristede Avraham, Rudi Levy, Raphael Feinmesser
Journal of Nuclear Medicine Feb 1994, 35 (2) 257-262;
Serum Thyroglobulin and Iodine-131 Whole-Body Scan in the Diagnosis and Assessment of Treatment for Metastatic Differentiated Thyroid Carcinoma
Ernesto Lubin, Sara Mechlis-Frish, Sofia Zatz, Aharon Shimoni, Karl Segal, Aristede Avraham, Rudi Levy, Raphael Feinmesser
Journal of Nuclear Medicine Feb 1994, 35 (2) 257-262;
Jump to section
Related Articles
- No related articles found.
Cited By...
- ENDOCRINE TUMOURS: Imaging in the follow-up of differentiated thyroid cancer: current evidence and future perspectives for a risk-adapted approach
- The role of FDG-PET in localization of recurrent lesions of differentiated thyroid cancer (DTC) in patients with asymptomatic hyperthyroglobulinemia in a real clinical practice
- Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECT
- 131I SPECT/CT in the Follow-up of Differentiated Thyroid Carcinoma: Incremental Value Versus Planar Imaging
- Is Empiric 131I Therapy Justified for Patients with Positive Thyroglobulin and Negative 131I Whole-Body Scanning Results?